24 results on '"Wargenau, Manfred"'
Search Results
2. A Semi-Mechanistic Population Pharmacokinetic Model of Noscapine in Healthy Subjects Considering Hepatic First-Pass Extraction and CYP2C9 Genotypes
3. A Composite Endpoint for Acceptability Evaluation of Oral Drug Formulations in the Pediatric Population
4. Double‐blind, randomized, 8‐week multicenter study of the efficacy and safety of STW 5‐IIversus placebo in functional dyspepsia.
5. Efficacy and Safety of STW 5-II for Functional Dyspepsia Treatment: A Patient Data-Based Meta-Analysis.
6. Questionnaire Study to Investigate the Preferences of Children, Parents, and Healthcare Professionals for Different Formulations of Oral Medicinal Products.
7. Evaluation of the pharmacoDYNAMIC effects of riociguat in subjects with pulmonary hypertension and heart failure with preserved ejection fraction: Study protocol for a randomized controlled trial
8. Evaluating the Acceptability, Swallowability, and Palatability of Film-Coated Mini-Tablet Formulation in Young Children: Results from an Open-Label, Single-Dose, Cross-Over Study.
9. Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial.
10. Pharmacokinetics and safety of 6 % hydroxyethyl starch 130/0.4 in healthy male volunteers of Japanese ethnicity after single infusion of 500 ml solution
11. Efficacy of the long-acting nitro vasodilator pentaerithrityl tetranitrate in patients with chronic stable angina pectoris receiving anti-anginal background therapy with beta-blockers: a 12-week, randomized, double-blind, placebo-controlled trial
12. Pharmacokinetics of the Generic Formulation Propofol 1% Fresenius in Comparison with the Original Formulation (Disoprivan® 1%)
13. Propofol anesthesia in spontaneously breathing children undergoing magnetic resonance imaging: comparison of two propofol emulsions
14. 330: EFFICACY AND SAFETY OF STW-5-II IN PATIENTS WITH FUNCTIONAL DYSPEPSIA: RESULTS FROM A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, 8-WEEK MULTICENTER TRIAL INCLUDING A POST-HOC ANALYSIS FOR PATIENTS MEETING FUNCTIONAL DYSPEPSIA ACCORDING TO ROME IV
15. Therapeutic potentials of acarbose as first-line drug in NIDDM insufficiently treated with diet alone.
16. DOSE FINDING STRATEGIES INVOLVING INTERIM ANALYSES AND UNBALANCED TREATMENT ALLOCATION.
17. Evaluation of the pharmacoDYNAMIC effects of riociguat in subjects with pulmonary hypertension and heart failure with preserved ejection fraction
18. DOSE FINDING STRATEGIES INVOLVING INTERIM ANALYSIS AND UNBALANCED TREATMENT ALLOCATION.
19. Acceptability of small-sized oblong tablets in comparison to syrup and mini-tablets in infants and toddlers: A randomized controlled trial.
20. Formulation-dependent food effects demonstrated for nifedipine modified-release preparations marketed in the European Union
21. Double-blind, randomized, 8-week multicenter study of the efficacy and safety of STW 5-II versus placebo in functional dyspepsia.
22. Blood glucose response after oral lactulose intake in type 2 diabetic individuals.
23. Blood glucose response after oral intake of lactulose in healthy volunteers: A randomized, controlled, cross-over study.
24. The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%, 500 mL) in mild-to-severe renal impairment.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.